SEC Filings
Filing date | Description | Form | Filing Group | Issuer | View |
---|---|---|---|---|---|
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
424B5 |
Registration Statements
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Registration of up to an additional 20% of securities for any offering registered on a S-3 |
S-3MEF |
Registration Statements
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
424B5 |
Registration Statements
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
424B5 |
Registration Statements
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Annual report which provides a comprehensive overview of the company for the past year |
10-K |
Annual Filings
|
Arcturus Therapeutics Holdings Inc. | EX-101.INS - XBRL INSTANCE DOCUMENT View HTML | |
Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Report of unscheduled material events or corporate event |
8-K |
Current Reports
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Arcturus Therapeutics Holdings Inc. | View HTML | |
Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Arcturus Therapeutics Holdings Inc. | View HTML |
Data provided by Kaleidoscope.